Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next?Unlock AI-picked Stocks

U.S. CDC plans to focus on public health response after pandemic failings

Published 08/17/2022, 12:29 PM
Updated 08/17/2022, 03:36 PM
© Reuters. FILE PHOTO: A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell

By Julie Steenhuysen

(Reuters) -The U.S. Centers for Disease Control and Prevention said it will prioritize its public health response in a revamp of its structure after months of criticism over its handling of the COVID-19 and monkeypox pandemics.

A briefing document provided by the agency on Wednesday said an external report into its response found public guidance had caused confusion, while important information were sometimes released too late to inform federal decisions.

CDC Director Rochelle Walensky said in response the agency was undertaking a series of changes designed to make it more nimble at responding, quicker at providing data and less focused on publishing fully vetted scientific papers.

"For 75 years, CDC and public health have been preparing for COVID-19, and in our big moment, our performance did not reliably meet expectations," Walensky told CDC staff.

"I want us all to do better and it starts with CDC leading the way," she said, adding that the focus will be on creating an "action-oriented" culture that emphasizes accountability, collaboration, communication and timeliness.

According to a background briefing document shared with Reuters, plans to modernize the agency include giving the CDC new authority to require states to report data and changes that will allow the CDC to hire staff more quickly and offer more competitive salaries. Both actions will require authorization from Congress.

As part of the changes, the CDC will name Mary Wakefield, former acting deputy secretary of the Department of Health and Human Services in the Obama administration, to lead a team to help implement the restructuring, the agency said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The steps follow the external review ordered by Walensky in April of its handling of the COVID-19 pandemic.

To encourage faster communication, Walensky wants to create an online mechanism to share findings before they are completely published and expedite the data review process.

Latest comments

When the CDC speaks one is wise to not listen, and if by accident your hear what they say you more than likely would be smart to ignore them.
maybe the CDC shouldn't have commercial interests in play when shoving public health policy down people's throats. how about that?
forget the fact that they lied to us;  we'll just do a fake restructuring (That'll probably cost taxpayers a pretty penny)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.